PHARMACTIVE PHARMACEUTICALSPharmactive Pharmaceuticals was founded in December 2010. The construction of Pharmactive production facility started on Valentine's Day, the 14th of February 2011. Pharmactive invested 200 million dollars in its production facility that has 330 million boxes of annual production capacity. The production facility is one of the largest and the most modern production facilities with its first stage having 42.500 square meters closed area. The facility will become one of the most important production facilities in Europe when its closed area reaches 80.000 square meters upon completion of the second stage and the production capacity increases to more than 550 million boxes. Considering the special requirements of drug manufacturing, the plant was constructed in accordance with international standards and is equipped with advanced building management systems. On February 2015, Pharmactive received European GMP certificate from Germany (BfArM).Pharmactive is aware of the fact that research and development activities will play an important role in the future of our company. With this awareness, Pharmactive founded PharmAr-GE which carries out clinical studies and product development practices with universities, phsicians and chemists with its incentivised "R&D center" status, and offers innovative solutions to the industry. With its flexible production ability and high capacity, Pharmactive offers contract manufacturing services which serves the needs and expectations of domestic and foreign companies. Pharmactive takes firms steps to rank among the top 5 pharmaceutical companies in Turkey by end of 2018.